ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
- PMID: 30878128
- DOI: 10.1016/j.critrevonc.2019.02.006
ALK rearrangements: Biology, detection and opportunities of therapy in non-small cell lung cancer
Abstract
The ALK receptor tyrosine kinase (ALK) gene encodes a transmembrane protein rearranged in 2-7% of non-small cell lung cancer (NSCLC) cases. This gene has become the second most studied therapeutic target after EGFR due to the implied therapeutic opportunities. While the diagnostic of ALK rearrangements is well established, small molecules targeting ALK are in constant evolution because tumor cells eventually will develop mechanisms of resistance. In this review we describe the biology of the ALK gene, alterations, epidemiology, diagnostic tests as well as strategies of treatment.
Keywords: ALK; Diagnostic tests; Non-small cell lung cancer; Tyrosine-kinase inhibitors.
Copyright © 2019 Elsevier B.V. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous